Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-10-27 05:34 UTC

Ingenia Therapeutics Gets US Approval for IGT-303 Phase 1/2a Trial

Ingenia Therapeutics received approval for the US clinical trial plan for IGT-303, a chronic kidney disease treatment.